Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Smith & Nephew Snats ADR (NY: SNN ) 27.71 UNCHANGED Streaming Delayed Price Updated: 7:00 PM EDT, Jul 15, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Smith & Nephew Snats ADR Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board July 09, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game June 26, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System June 12, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire 4 Stocks to Watch in the Booming Regenerative Medicine Market May 20, 2024 Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than... Via TheNewswire.com Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention April 18, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE) April 04, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds April 01, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner March 25, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement February 28, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting February 13, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting February 12, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting February 12, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire New study confirms Smith+Nephew’s REGENETEN™ Bioinductive Implant reduces full-thickness rotator cuff re-tear rates¹ by 68% January 11, 2024 From Smith & Nephew UK Ltd Via GlobeNewswire Santa Rally comes early for these stocks November 29, 2023 The analysts are upgrading these stocks and are helping an early Santa Claus Rally drive their prices to new highs, with a double-digit upside ahead. Via MarketBeat Surgical Centers, Med-Tech Stocks Up On Pent-Up Surgical Demand June 16, 2023 Surgery centers and medtech firms see a surge in demand as joint replacements and other elective surgeries are rescheduled, causing challenges for insurers. Via MarketBeat 3 Healthcare Dividend Payers With Big Price Growth April 14, 2023 Sanofi, AstraZeneca and Smith & Nephew all boast price performance better than about 80% of the broader market, and all are dividend payers. Via MarketBeat Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.